Life Sciences Greenhouse of Central Pennsylvania

A Venture Capital Investment Company for Life Sciences Enterprises in Central Pennsylvania

  • About Us
    • About LSGPA
    • Our Team
    • Board of Directors
  • The Funding Process
  • Resources
    • The Ecosystem
    • Applicant Support
    • Why Central PA?
  • Portfolio Companies
    • Portfolio Overview
    • Devices and Diagnostics
    • Drug Discovery
    • Other
  • News and Events
    • Press Releasees
    • Video Gallery
  • Apply Now
  • Contact Us

Archives for April 2018

FDA OKs AI software to detect diabetic retinopathy

April 12, 2018 By Admin

Apr. 11, 2018 12:51 PM ET|By: Douglas W. House, SA News Editor

Under its De Novo (no predicate product) review pathway, the FDA approves the first medical device in the U.S. that uses artificial intelligence (AI) to perform its designated function. The device, called IDx-DR, is a software program used to detect greater than a mild level of diabetic retinopathy.

IDX-DR employs an AI algorithm to analyze eye images taken with a retinal camera called the Topcon NW400. The physician uploads the digital images to a cloud server with the software and, if the images are of sufficient quality, receives one of two responses: “more than mild diabetic retinopathy detected: refer to an eye care professional” or “negative for more than mild diabetic retinopathy; rescreen in 12 months.”

IDX-DR is the first FDA-approved device that provides a screening decision without a supporting interpretation from a clinician which allows it to be used by healthcare providers who are not normally involved in eye care. It was developed by privately held IDx LLC.

Diabetic retinopathy-related tickers: OTCQX:RHHBY, REGN, OTCQB:ARPO, MNTA, MYL, OTCPK:TBGNF, AERI, ALIM, CHRS, OTCPK:BAYRY

Filed Under: News and Events

Latest News

Immunomic Therapeutics Licenses Investigational Canine Dermatitis Therapy to ZENOAQ

17:00 EST 6 Feb 2019 | Businesswire Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today … Read More...

THE LIFE SCIENCES GREENHOUSE OF CENTRAL PA PUMPED NEARLY $2.5 MILLION INTO CENTRAL PENNSYLVANIA STARTUPS IN 2018 Investments Catalyzed $23 Million in Follow-On Funding from Other Sources

HARRISBURG, Pa.-- The Life Sciences Greenhouse of Central Pennsylvania ( www.LSGPA.com ) invested just under $2.5 million last year in three … Read More...

Saladax Submits for FDA Review a Rapid Blood Test for Levels of Risperidone

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical Inc., a diagnostics company providing kits to test drug blood levels for adherence and … Read More...

Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels for adherence and … Read More...

LSGPA is pleased to have sponsored the 2018 Women in Tech Gala

LSGPA is pleased to have sponsored the 2018 Women in Tech Gala.  Congratulations to all award recipients. Click the link below to read more about … Read More...

Archives

  • February 2019
  • January 2019
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • July 2017
  • June 2017
  • March 2017
  • January 2017
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • May 2016
  • January 2016
Facebook
Twitter

LSGPA
Life Sciences Greenhouse of Central Pennsylvania
225 Market Street
Suite 500
Harrisburg, PA  17101
1-717-635-2100

Strawberries
LSGPA Copyright © 2018

Copyright © 2019 · WordPress · Log in